KIGAMICIN C 化学特性,用途語,生産方法 |
使用
Kigamicin C was discovered by an anti-austerity strategy, targeting cancer cells' tolerance to starvation. It selectively kills PANC-1 cells (a pancreatic cell line) at concentrations 100 times lower under nutrient starved conditions than in normal conditions. The mechanism of action is proposed to be via blockade of aPKB/Akt activation, caused by the withdrawal of nutrients. It is active in vivo against a human pancreatic cancer xenograft model. Kigamicin C also inhibits the growth of Gram positive bacteria including MRSA, but is not active against Gram negative bacteria. |
|
|
| KIGAMICIN C 上流と下流の製品情報 |
原材料
|
準備製品
|
| KIGAMICIN C 生産企業 Global( 1)Suppliers |
|
|
|